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Background
Activating the herpesvirus lytic replication cycle presents
an opportunity for targeted therapy. We explored the
effects of endoplasmic reticulum (ER) stress inducers on
Kaposi’s sarcoma herpesvirus (KSHV) lytic activation in
primary effusion lymphoma (PEL) cell lines. We included
nelfinavir (an HIV-1 protease inhibitor) in our investiga-
tions because it has been reported to induce ER stress in
various tumor cell lines [1]. Treatment with bortezomib,
thapsigargin or nelfinavir resulted in increased expression
of ER stress markers such as activating transcription fac-
tor 4 (ATF-4) and the spliced form of X-box binding pro-
tein 1 (XBP-1(s) (see figure 1). Treatment was also
associated with an increase in RNA expression of the
KSHV immediate early “replication and transcriptional
activator” (RTA) (see figure 2). To determine whether ER
stress mediated KSHV lytic reactivation associated with
these agents, we prepared doxycycline-activated short
hairpin RNA knockdowns of ER stress genes (Grp78 and
XBP-1(s)). Treatment of these knockdowns with doxycy-
cline for 72 hours resulted in inhibition of ER stress and
inhibition of viral lytic gene expression.
Conclusion
These results demonstrate that in KSHV-infected cell
lines, induction of ER stress is associated with activation
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Figure 1 Treatment of BC-3 cells leads to induction of ER stress markers. KSHV PEL cells (BC-3) were treated with DMSO, 20nM bortezomib
(20nm BZ), 1mM thapsigargin (1mM TG) or 72uM nelfinavir (72uM NFV). RNA was isolated and RT-PCR was performed using primers for ATF-4
and XBP-1(s). Primers for b-actin were used as an internal control. Error bars indicate SEM.
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any medium, provided the original work is properly cited.of KSHV lytic genes and raises the possibility that nelfi-
navir might be incorporated into future treatment stra-
tegies for KSHV-associated malignancies.
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Figure 2 ER stress inducers activate KSHV lytic gene expression.
KSHV BC-3 cells were treated with DMSO, 20nM bortezomib (20nm
BZ), 1mM thapsigargin (1mM TG) or 72uM nelfinavir. RNA was
isolated and RT-PCR was performed using primers for RTA. Primers
for b-actin were used as an internal control. Error bars indicate SEM.
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